Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization

Maxime Taquet, Zuzanna Skorniewska, Adam Hampshire, James D. Chalmers, Ling-Pei Ho, Alex Horsley, Michael Marks, Krisnah Poinasamy, Betty Raman, Olivia C. Leavy, Matthew Richardson, Omer Elneima, Hamish J. C. McAuley, Aarti Shikotra, Amisha Singapuri, Marco Sereno, Ruth M. Saunders, Victoria C. Harris, Linzy Houchen-Wolloff, Neil J. Greening, Parisa Mansoori, Ewen M.…[...]

Read More

COVID-19 Long-haul Fatigue Might be Similar to Chronic Fatigue Syndrome and Treated in a Similar Manner

There is no cure or approved treatment for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). However, some symptoms can be treated or managed. Treating these symptoms might provide relief for some patients…[...]

Read More

Neurological manifestations of post-acute sequelae of COVID-19: which liquid biomarker should we use?

Dominique Comeau1† Mykella Martin2† Gilles A. Robichaud3,4,5 Ludivine Chamard-Witkowski2,6*1Dr. Georges-L. Long COVID syndrome, also known as post-acute sequelae of COVID-19 (PASC), is characterized by persistent symptoms lasting 3–12 weeks post SARS-CoV-2 infection. Patients suffering…[...]

Read More

Most long-COVID sufferers battle neurological symptoms, including some cognitive issues never seen before

Authors: Jocelyn Solis-Moreira JUNE 20, 2022 https://www.braintomorrow.com/ People continue to experience neurological problems six months after recovering from a COVID-19 infection, finds a recent study from the University of California…[...]

Read More

Lifestyle risk behaviors among adolescents: a two-year longitudinal study of the impact of the COVID-19 pandemic

Authors: Anne Gardner1, Jennifer Debenham1, Nicola Clare Newton1, Cath Chapman Fiona Elizabeth Wylie2, Bridie Osman1, Maree Teesson, Katrina Elizabeth Champion The British Medical Journal Abstract Objective To examine changes in the prevalence of six key chronic…[...]

Read More